Aconite (Aconitum spp.)
1. Identity: Botanical Names, Natural Source, and Common Forms
Aconitum napellus — commonly called monkshood, aconite, Venus' chariot, or wolfsbane — is a species of highly toxic flowering plant in the genus Aconitum of the family Ranunculaceae, native and endemic to western and central Europe. It is a perennial herbaceous plant growing to approximately 1 m tall, with hairless stems and leaves. The flowers are dark purple to bluish-purple, with narrow oblong helmet-shaped sepals 1–2 cm tall.
In pharmacognosy, the official drug substance "Aconite" refers to the dried roots of Aconitum napellus Linn., collected from wild or cultivated plants belonging to the family Ranunculaceae. Common synonyms include monkshood, Friar's cowl, mouse-bane, aconite root, Mit-hazahar (Hindi), and Radix aconiti.
The plant originated in the mountainous and temperate regions of Europe; it occurs in the Alps and Carpathian mountains, the hills of Germany, and the Himalayas. The greater part of the commercial drug is derived from wild plants grown in central and southern Europe, particularly Spain.
The broader genus Aconitum comprises over 350 different species of perennial flowering plants that grow in temperate mountainous areas of the Northern Hemisphere, spanning North America, Europe, and Asia.
The genus includes several medicinal species used across different traditional systems:
- Aconitum carmichaelii Debeaux (lateral root), known as Fuzi (附子) in TCM and officially monographed as Aconiti Lateralis Radix Praeparata in the Chinese Pharmacopoeia (2020 edition).
- Aconitum carmichaelii-derived medicine is processed into Chuanwu (Radix Aconiti praeparata) from the mother root and Fuzi (Radix Aconiti lateralis praeparata) from the lateral root in Traditional Chinese Medicine — two useful drugs with toxic properties.
- Aconitum heterophyllum (Wall.), known as Atis root, grows in the western temperate Himalayas. This species does not contain aconitine and is said to be non-poisonous; its chief constituent is the intensely bitter alkaloid atisine, which possesses tonic and antiperiodic properties.
- Aconitum kusnezoffii Reichb., commonly known as aconite, derives its name from the Greek word "Aconiton" used by Theophrastus. This species has been integral to TCM, Korean medicine, and Ayurveda for centuries, gaining significance due to its diverse alkaloid content ranging from non-toxic to highly toxic compounds.
Common Preparations and Dosage Forms
From the root of Aconitum napellus, a liniment and a tincture are the classical prepared forms. Historically, extract of aconite roots was used internally for rheumatism and gout, prepared as pills or drops for oral administration; tincture was used internally for neuralgia; the extract was also used externally in liniments for rubbing. The internal use of aconite herb prepared in powders and pills for rheumatism, gout, and neuralgia was documented in France.
In contemporary Western markets, most aconite products are homeopathic, meaning they are very dilute and contain only very small amounts of aconite — sometimes so small that there may not be any aconite in the product at all. The very small amounts of aconite found in homeopathic products are unlikely to cause serious side effects.
2. Traditional and Historical Use
Ancient and Classical Greek and Roman Use
The toxicity of Aconitum napellus is mentioned in Greek mythology, where it is described as the first poisonous plant. In fact, aconite is considered the most poisonous plant in central Europe due to its alkaloid aconitine. Many species of the genus have been used for many centuries as arrow poison and in homicides.
A. napellus has a long history of use as a poison, with cases going back thousands of years. During the ancient Roman period, the plant was often used to eliminate criminals and enemies, and by the end of that period it was banned — anyone growing A. napellus could have been legally sentenced to death. It was recorded that Agrippina, wife of the Roman emperor Claudius, poisoned him with aconite, which could not only mimic an apoplectic insult but also cause severe pain.
Persian physician Avicenna (980–1037) wrote that arrows dipped in the sap were used to kill, and Dr. Antonio Guaineri, in one of the first medical dictionaries, Practica, wrote that arrows with poison from the roots of the plant were used to kill wild goats in Italy.
Traditional Chinese Medicine (TCM)
Aconitine is the dominant ingredient responsible for the biological activity and therapeutic efficacy of Aconitum plants such as Fuzi, Caowu, and Chuanwu, which have been used as TCM medicines for over 2,000 years and are officially recorded in the Chinese Pharmacopoeia.
Fuzi (the processed lateral root of Aconitum carmichaelii) is a TCM botanical drug used for "restoring depleted Yang and rescuing collapse" (回阳救逆, Huí Yáng Jiù Nì). It possesses effects of tonifying fire to reinforce Yang and dispelling cold to alleviate pain, and is clinically used for conditions such as devastated Yang collapse, heart Yang insufficiency, and pain due to cold-damp bi-syndrome.
In TCM, processed Fu Zi aconite treats conditions like rheumatism, bruises, bronchitis, and certain heart diseases. It is prepared by prolonged boiling or steaming to reduce its toxicity and concentrate active compounds. In TCM, processed aconite is sometimes called the "King of 100 Herbs" and is famous for tonifying Yang; it is used to treat heart disease, chronic and severe conditions, and pain.
Prolonged boiling is a traditional rural method of processing the Aconitum herb to reduce its toxicity. Paozhi is the Chinese term for processing crude herbal drugs using specific methods that can reduce the toxicity of the drug while maximizing its effectiveness. There can be more than one method to process the same herb, which can bring about different pharmacological functions.
Ayurvedic Medicine
Vatsanabha (aconite) has a place in Ayurvedic materia medica since antiquity, though with a clear caution before use. Ayurveda explains that a deadly material can be turned into a lifesaver depending upon the methods of use, and proposes a traditional purification technique (Shodhana) to reduce the harmful effects associated with Vatsanabha.
Vatsanabha (Aconitum ferox Wall.) is a well-known ingredient of Ayurvedic formulations and is prescribed as an antipyretic, analgesic, anti-rheumatic, appetizer, and digestive. The recommended dose of purified Vatsanabha root in this tradition is 15 mg.
European Herbal Medicine
Medicinal use of aconite roots was described in the German handbook Handbuch der allgemeinen und speziellen Arzneiverordnungslehre für Ärzte (1929). Extract of aconite roots was used internally for rheumatism and gout, prepared as pills or drops for oral administration. Tincture of aconite roots was used internally for neuralgia. The extract was also applied externally in liniments for rubbing.
Aconite extract was used externally for trigeminal neuralgia, lumbago, sciatica, arthritis, gout, and rheumatism, due to its anesthetic properties. In the twentieth century, several reported toxicity cases directly decreased the use of aconite in herbal prescriptions in European and American countries.
Nepalese and Tibetan Use
Nepalese medicinal systems use mainly the rootstocks and leaves of locally grown species like A. spicatum. Tamang healers apply hot leaves on swollen joints and prepare decoctions of roots as bitter tonics in small doses.
3. Key Constituents and Active Compounds
Alkaloid Classes
The primary bioactive and toxic compounds in Fuzi (and Aconitum species broadly) are the C19-diester-diterpenoid alkaloids (DDAs), predominantly comprising aconitine (AC), mesaconitine (MA), and hypaconitine (HA). C19 diterpenoid alkaloids are subdivided into various types — including aconitine, lycoctonine, pyro-type, lactone-type, 7,17-seco-type, and rearranged-type — based on specific oxygen-containing groups and structures at the C-7 position.
The principal toxic compounds in aconite are diester diterpene alkaloids (DDAs) such as aconitine, mesaconitine, and hypaconitine. Aconite also contains monoester diterpene alkaloids (MDAs) such as benzoylaconine, benzoylmesaconine, and benzoylhypaconine, which have comparatively lower toxicity and are of more medicinal value.
The basic skeleton of the aconite alkaloid consists of a pentacyclic diterpene. Biologically active isolates from Aconitum and Delphinium plants are classified as norditerpenoid alkaloids, further subdivided based on the presence or absence of the C18 carbon. Aconitine is a C19-norditerpenoid based on the presence of this C18 carbon. It is barely soluble in water but very soluble in organic solvents such as chloroform or diethyl ether.
Some Aconitum species also contain lappaconitine, structurally similar to aconitine. In contrast to aconitine — a sodium channel agonist — lappaconitine reportedly blocks voltage-gated sodium channels in heart tissue.
The pharmacological value of Aconitum species is largely attributed to secondary metabolites including alkaloids, flavonoids, saponins, tannins, glycosides, terpenoids, free fatty acids, and polysaccharides.
Transformation Through Processing
All three processing methods used in Ayurveda and TCM effectively extract the diester diterpenoid alkaloids and lead to their conversion into monoester diterpenoid alkaloids. The efficiency of processes in reduction of toxic alkaloid contents can be stated as: processing with water > Shodhana with cow milk > Shodhana with cow urine. Both traditional systems of medicine efficiently detoxify the aconite roots; the TCM method of decoction with water is the most efficient among the selected procedures.
Processing converts highly toxic aconitine to less toxic benzoylaconine and aconine. Key bioactive constituents of processed Fu Zi include alkaloids — aconitine, mesaconitine, hypaconitine, and benzoylaconine.
4. Mechanisms of Action
Sodium Channel Activation
Aconitine can interact with voltage-dependent sodium-ion channels, which are proteins in the cell membranes of excitable tissues such as cardiac and skeletal muscles and neurons. These proteins are highly selective for sodium ions. They open to quickly depolarize the cell membrane, causing the upstroke of an action potential. Normally, the sodium channels close again very rapidly, but the action potential causes the opening of potassium channels and potassium efflux, resulting in repolarization of the membrane.
Aconitine binds to the channel at the neurotoxin binding site 2 on the alpha subunit — the same site bound by batrachotoxin, veratridine, and grayanotoxin — and this binding results in a sodium-ion channel that stays open longer.
Aconitine possesses a high and specific binding affinity for neurotoxin-binding site 2 on the alpha-subunit of the Na+ channel protein in cardiac myocytes, muscles, and nerves, causing their persistent activation, refraction to a new excitation, and hyperpolarization as a consequence of the massive influx of sodium inside the cells.
As documented in the IUPHAR/BPS Guide to PHARMACOLOGY, aconitine is documented as an activator (partial agonist) for voltage-gated sodium channels (Nav) across both human and rat species. These channels serve a pivotal role in the generation and propagation of action potentials within excitable tissues, encompassing the heart and nerves. In human physiology, aconitine functions as a partial agonist for the sodium channel protein type 5 subunit alpha (Nav1.5).
Cardiac Effects
Na+ overload caused by the aconitine-modified voltage-gated Na+-dependent channels induces shortening of action potential duration, and increased Ca2+ provides an arrhythmogenic delayed afterdepolarization. By activating the ventromedial nucleus of the hypothalamus, aconitine also has hypotensive and bradycardic properties.
Prior studies confirmed that aconitine blocks the inactivation of voltage-dependent sodium channels, causing persistent Na+ influx at resting potential and thereby leading to arrhythmia. Moreover, aconitine diminishes the amplitude of delayed rectifier K+ current in Jurkat T-lymphocytes, which probably affects the function of immune cells.
Neuromuscular Effects
Through its perpetuating action on axon-dependent voltage-gated Na+ channels, aconitine blocks neuromuscular transmission by increasing or decreasing the release of acetylcholine levels from the motor nerve.
Anti-inflammatory Mechanisms
Aconitine has shown efficacy in anti-inflammation — for instance, in the treatment of rheumatoid arthritis — by regulating IL-6 and TNF-α cytokine levels and inhibiting the activation of the NF-κB signaling pathway.
Antitumor Mechanisms (Preclinical)
The antitumor action mechanism of aconitine is primarily to induce apoptosis and inhibit cancer cell proliferation and migration. A systematic review and meta-analysis of preclinical studies analyzed tumor cell proliferation, apoptosis rate, thymus index, and Bcl-2 gene expression. After applying the final inclusion criteria, a total of 37 in vivo and in vitro studies were analyzed. The results showed that treatment with aconitine led to significant reduction in tumor cell proliferation, a noteworthy increase in apoptosis rate among tumor cells, a decrease in the thymus index, and a reduction in the expression level of Bcl-2.
5. Scientific Evidence by Area of Use
5.1 Pain and Analgesia
Extracts of Aconitum spp. are used in traditional Chinese medicine predominantly as anti-inflammatory and analgesic agents — the latter allegedly equally potent as morphine but without any habit-forming potential. The C19 diterpenoid alkaloid aconitine, and some of its derivatives, have been proven antinociceptive in different analgesic assays, though the mode of action is not fully understood.
Pharmacological studies have confirmed that the alkaloids contained in aconite are of great value in treating mild-to-moderate pain, including neuropathic pain, osteoarthralgia, and cancer pain. In addition to toxicity, natural substances derived from Aconitum species may have a range of biological effects including analgesic, anti-inflammatory, and anti-cancer characteristics. Multiple in silico, in vitro, and in vivo studies have demonstrated the effectiveness of these therapeutic effects.
Evidence strength: All of these pharmacological effects require further high-quality studies to determine the clinical efficacy of aconitine. Evidence for analgesic effects remains largely preclinical (animal and in vitro) with no robust human randomized controlled trials published as of the most recent systematic literature searches.
5.2 Anti-inflammatory Effects (Rheumatism, Arthritis)
Preparations of Aconitum roots are employed in Chinese and Japanese medicine for analgesic, antirheumatic, and neurological indications. Modern pharmacological research confirms that the main active metabolites of processed aconite (Fuzi) — including diterpenoid alkaloids, flavonoids, and steroidal saponins — possess anti-inflammatory, analgesic, cardiotonic, and immunomodulatory effects.
Evidence strength: The anti-inflammatory evidence for aconitine is based on in vitro and animal models, with demonstration of effects on NF-κB signaling and cytokine modulation. Controlled human clinical trials specific to anti-inflammatory efficacy are lacking. Further high-quality studies are required to determine clinical efficacy.
5.3 Cardiovascular System
Research confirms significant cardiotonic effects (positive inotrope), vasodilatory action, anti-inflammatory effects, and anti-arrhythmic properties at therapeutic doses. Fuzi (processed aconite) demonstrates pharmacological properties including cardiotonic, antiarrhythmic, anti-inflammatory, analgesic, and antitumor effects, but also exhibits toxicities due to its diterpenoid alkaloid constituents.
Many clinical reports have shown that the same dose of aconitine has different effects on patients with varied physical conditions. The mechanism is controversial.
Evidence strength: Cardiotonic and antiarrhythmic effects of processed aconite formulations are recognized in TCM clinical practice, but rigorous randomized controlled trial evidence in Western clinical frameworks remains limited. The cardiovascular toxicity of unprocessed or overdosed aconite is extensively documented in case reports (see Safety section).
5.4 Antitumor Activity
Aconitine has gained attention for its exceptional anti-inflammatory and analgesic properties, as well as its potential as an anti-tumor and cardiotonic agent. Several animal and cellular experiments have confirmed the inhibitory effect of aconitine alkaloids on malignant tumors. Aconitine shows powerful antitumor potential in a variety of tumors and has good prospects for development and application.
However, the exact process through which aconitine hinders the growth of cancerous cells and triggers their programmed cell death remains unclear.
Evidence strength: Numerous preclinical studies have demonstrated that aconitine has a notable inhibitory effect on malignant tumors. The search for aconitine's extensive preclinical evidence of inhibiting malignant tumors and promoting apoptosis of malignant tumor cells in vitro and in vivo can help expand the clinical application of aconitine and the subsequent development of related anticancer drugs. No human clinical trials of aconitine as an anti-cancer agent have been identified in peer-reviewed literature; all current evidence is preclinical.
5.5 Homeopathic Use
In homeopathic practice today, Aconitum napellus is primarily used for acute medical presentations including sudden high fever with chills, fever associated with stitching pains, fever or chill associated with restlessness and anxiety, and particularly fevers that start around midnight.
Evidence strength: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. The FDA is not aware of scientific evidence to support homeopathy as effective. While many homeopathic products are highly diluted, some products sold or labeled as homeopathic may not be; they can contain substantial amounts of active ingredients, which may cause side effects or drug interactions. No specific high-quality randomized controlled trials have demonstrated efficacy of homeopathic aconite preparations for any indication.
6. Body Systems and Health Areas Associated with Aconite
Aconitine exerts its principal pharmacological and toxicological effects on the cardiovascular system, nervous system, digestive system, liver, and kidney. The body systems most implicated in both therapeutic use and toxicity are:
- Cardiovascular system: The mechanism of action of the pharmacologically active compounds in aconite relates to the activation of voltage-gated sodium channels within a range of tissues including myocardial, neuronal, and smooth muscle, leading to persistent cellular activity.
- Nervous system: The aconite alkaloids are toxic to the nervous system, cardiac and muscle tissue. Aconitine molecules bind to the open state of voltage-sensitive sodium channels and prevent their deactivation. The persistent activation of sodium channels interferes with neurotransmitter release and regulation of electrical activity, affecting nerve function and neuromuscular transmission, and leading to irregular heart rhythm.
- Musculoskeletal system: Traditional use centers on pain relief in rheumatism, arthritis, gout, sciatica, and neuralgia — primarily through topical preparations.
- Immune and endocrine systems: Fuzi's alkaloids possess a broad spectrum of pharmacological effects including anti-inflammatory, anticancer, immunoregulatory, analgesic, and nephroprotective properties.
- Digestive system: In oral exposure to aconitine, the patient first experiences gastrointestinal clinical effects, primarily an itchy, burning sensation of the mouth, lips, throat, and tongue, later followed by nausea, vomiting, diarrhea, intense sleep, colicky pain, and constriction of the throat.
7. Dosage Forms and Dosages Reported in Sources
In TCM, typical dosages reported are 2–12 grams of processed Fu Zi per day in decoctions. Raw aconite is rarely used internally.
The Chinese Pharmacopoeia (2020 edition) limits the contents of DDAs and MDAs in Fu Zi, stipulating an upper limit of DDAs (less than 0.020%) and a lower limit of MDAs (more than 0.010%), so that these six aconitum alkaloids serve as quality marker compounds for the chemical evaluation of Fu Zi.
In Ayurveda, the recommended dose of purified Vatsanabha (A. ferox Wall.) root is 15 mg.
Herbal formulae used in traditional soups did not adhere to suggested guidelines with regard to doses (50–500 g instead of 3–30 g per person) and types (raw instead of processed) of aconite roots used. This deviation from protocol is a common cause of poisoning events.
Traditional Western texts recommended specific doses, and severe poisoning has been caused even by ingestion of 0.2 mg of pure aconitine, or by decoctions with 6 g of Aconitum roots.
8. Safety: Toxicity, Clinical Presentations, and Drug Interactions
8.1 Acute Toxicity and Lethal Doses
Consuming as little as 2 milligrams of pure aconitine or 1 gram of the plant itself may cause death by paralyzing respiratory or heart functions. Toxicity may also occur through the skin; even touching the flowers can numb the fingertips.
Death usually occurs from ventricular arrhythmia within the first 24 hours after intake of Aconitum preparations. Aconitine half-life has been reported to be approximately 3 hours, and intoxication symptoms may persist for 30 hours. In vitro experiments have demonstrated that human skin is permeable to aconitine and mesaconitine, and poisoning following topical use is described in the literature, especially in cases of application on damaged epidermis.
Aconitine's minimal lethal dose is 3–6 mg. One gram of fresh Aconitum napellus may contain 2–20 mg of aconitine. Therefore, small amounts of this plant can be lethal.
8.2 Clinical Manifestations of Poisoning
The clinical manifestations of aconite poisoning may encompass gastrointestinal symptoms, sensory alterations, seizures, and life-threatening dysrhythmias that may not respond to standard treatments.
Aconitine's toxicity is characterized by a burning or tingling sensation of the lips, tongue, mouth, and throat almost immediately following ingestion. Numbness of the throat, difficulty with speech, salivation, nausea, vomiting, dizziness, and diarrhea may occur, as well as visual blurring or yellow-green color vision distortion, weakness, and incoordination.
A combination of neurological, gastrointestinal, and cardiovascular signs and symptoms is seen in aconitine poisoning. Ventricular tachyarrhythmias have been documented in approximately 18% of subjects in reviewed series.
The highest mortality rates have been associated with refractory ventricular tachycardia.
8.3 Multi-Organ Toxicity
Improper use of aconitine can result in severe cardiac arrhythmias, shock, and coma. Aconitine affects voltage-sensitive sodium channels in excitable tissues such as cardiac muscle, nerve, and muscle, leading to cardiotoxicity and neurotoxicity. Studies have also shown that aconitine can cause embryotoxicity, nephrotoxicity, hepatotoxicity, and reproductive toxicity.
8.4 Poisoning from Contamination
Aconitum alkaloid poisoning can occur after drinking decoction and soup made from nominally non-toxic herbs contaminated by aconite roots. A review of 40 cases reporting Aconitum poisoning in mainland China from 2004 to 2015 suggested that a majority of cases appeared in persons who believed in the medicinally beneficial effect of Aconitum in its toxic (unprocessed) form. A local review from the Hospital Authority of Hong Kong on 52 cases of Aconitum poisoning from 2004 to 2009 suggested that overdosing is the major underlying cause of poisoning.
8.5 Treatment of Poisoning
There is no direct antidote to aconitine poisoning; essential vital support and treatment must be given accurately and effectively. Supportive management is the mainstay of treatment. This includes vigilant monitoring of vital signs, with supportive cardiovascular management in the form of intravenous fluid and rhythm control involving amiodarone for tachyarrhythmias and atropine for bradycardia.
Amiodarone, flecainide, procainamide, mexiletine, lidocaine, magnesium sulfate, and other medications, as well as electrical cardioversion, have all been investigated with varying degrees of effectiveness.
Although activated charcoal is effective in reducing the absorption of many toxins, its efficacy in aconite poisoning is debated because of the rapid absorption of aconitine and the potential for exacerbating gastrointestinal symptoms.
8.6 Drug Interactions and Combination Toxicity
In addition to ginseng and licorice, combination of aconite with other herbs can significantly reduce toxicity. Common formulas include Ganjiang Fuzi Decoction (combining dried ginger with aconite), Zhenwu Decoction (combining white peony root, large-head atractylodes rhizome, poria, and aconite), and Dahuang Fuzi Decoction (comprising rhubarb, fine-leaf asarum, and aconite). The detoxification mechanism includes chemical degradation: carboxyl-containing acidic components in dried ginger undergo acid-base neutralization with aconitine, promoting the hydrolysis of diester-type alkaloids into lipid-formaldehyde-type alkaloids.
In combination treatments, aconitine shows antiarrhythmic and anti-inflammatory activity, a synergistic antiproliferative effect, and decreased reactive oxygen species (ROS) generation, as well as improved biodistribution and bioavailability.
Conversely, because aconitine causes persistent sodium channel opening with attendant risk of cardiac arrhythmia, concurrent use with other drugs that affect cardiac conduction — including antiarrhythmic agents of Class I or III, digoxin, and QT-prolonging pharmaceuticals — represents a clinically significant interaction documented through case-report literature and toxicology reviews.
8.7 Regulatory Status
Plants native to Asia and North America formerly listed as A. napellus are now regarded as separate species. The plant is extremely poisonous whether by ingestion or body contact. In the United Kingdom, aconite is listed on the Medicines and Healthcare products Regulatory Agency (MHRA)'s schedule of banned and restricted herbal ingredients for medicinal use under the Human Medicines Regulations 2012 (Schedule 20). In the United States, homeopathic aconite products are marketed as unapproved homeopathic products; the FDA is not aware of scientific evidence to support homeopathy as effective.
With the use of appropriate processing methods, good quality control of the preparations, and prescription by experienced practitioners, intoxications with aconite could theoretically be avoided. However, processing and compatibility are the primary means to reduce Fuzi toxicity, and establishing a reasonable unified safe dose range requires further discussion.
References
Go back